Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early...

Dr Edith Perez - Mayo Clinic, Rochester, USA

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early...

Dr Edith Perez - Mayo Clinic, Rochester, USA

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early-stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

Adjuvant exemestane more effective than tamoxifen when combined with ovarian...

Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona...

Adjuvant exemestane more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer ( Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian...

Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona...

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer ( Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Comment: Advances in breast cancer presented at ASCO 2014

Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland

Comment: Advances in breast cancer presented at ASCO 2014 ( Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland )

Vitamin D as a prevention against breast cancer

Dr Song Yao - Roswell Cancer Center Institute, New York, USA

Vitamin D as a prevention against breast cancer ( Dr Song Yao - Roswell Cancer Center Institute, New York, USA )

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA

Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio...

"Exciting" implications of bemacyclib study in the treatment of breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )

Study identifies new strategy to overcome breast cancer resistance to HER2...

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies ( Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA )

New drug demonstrates early promise in metastatic breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio...

New drug demonstrates early promise in metastatic breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )

Promising research on the use of palbociclib in the treatment of breast cancer

Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Promising research on the use of palbociclib in the treatment of breast cancer ( Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

More from ecancer